Utility Values Across Lines of Therapy in Immuno-Oncology Treatments- An Example from Advanced Melanoma
Abstract
Authors
D Tilden W Sierakowski S Cottrell H Kim
D Tilden W Sierakowski S Cottrell H Kim
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now